Previous 10 | Next 10 |
Palm Beach, FL – June 8, 2021 – The recent pandemic has, as we all know, negatively affected almost every business and financial markets across the globe… and even the seemingly ever increasing Cannabidiol markets. The global COVID-19 pandemic outbreak has had an unprec...
– Evaluating the safety, tolerability, and efficacy of intravenous (IV) temanogrel for cMVO in adult participants undergoing percutaneous coronary intervention (PCI) – Currently no FDA approved therapies indicated for the treatment of cMVO – Temano...
Among its top stock picks for 2021, Credit Suisse especially likes six names among its 40 top outperform ideas.Credit Suisse Product Manager Andrew St. Pierre says the names are the "highest conviction combined with the least demanding market expectations," in a note out today.The top stocks ...
- Improvement by two score levels to "A" following the Company’s 2021 ESG Report launch underscores Arena's long-term commitment to ESG principles Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that as of 2021, Arena received an MSCI ESG Rating of "A."...
Often, weak stocks going into a market correction or bear move will decline faster than the main indexes. I have listed 20 stocks/ETFs out of a 4000+ sort universe experiencing a rush of selling since March. Aggressive selling on up and down days, with clear relative price weaknes...
- ISS ESG Corporate Rating uses comprehensive research and data to allow institutional investors to identify Environmental, Social and Governance (ESG) risks and seize investment opportunities - Inaugural year of Prime status for Arena, following the Company’s 2021 ESG ...
Image source: The Motley Fool. Arena Pharmaceuticals Inc (NASDAQ: ARNA) Q1 2021 Earnings Call May 5, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Arena Pharmaceuticals Inc (ARNA) Q1 2021 Earnings Call Transcript ...
Arena Pharmaceuticals, Inc. (ARNA) Q1 2021 Earnings Conference Call May 05, 2021, 16:30 ET Company Participants Patrick Malloy - VP, IR & Corporate Communications Amit Munshi - President, CEO & Director Laurie Stelzer - EVP & CFO Conference Call Participants Kennen MacKay - RBC Ca...
Arena Pharmaceuticals (ARNA): Q1 GAAP EPS of -$1.98 beats by $0.20.Cash, cash equivalents and marketable securities of $1.1B.Press Release For further details see: Arena Pharmaceuticals EPS beats by $0.20
– Liquidity position at $1.1 billion as of March 31, 2021 to support continued pipeline progress Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial results for the first quarter ended March 31, 2021. "Over the q...
News, Short Squeeze, Breakout and More Instantly...
Arena Pharmaceuticals Inc. Company Name:
ARNA Stock Symbol:
NASDAQ Market:
Arena Pharmaceuticals Inc. Website:
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) traded at a new 52-week high today of $99.95. So far today approximately 748,000 shares have been exchanged, as compared to an average 30-day volume of 1.2 million shares. Arena Pharmaceuticals is a biotechnology company targeting G-protein-couple...
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) traded today at a new 52-week high of $98.57. So far today approximately 748,000 shares have been exchanged, as compared to an average 30-day volume of 1.1 million shares. Over the past year, Arena Pharmaceuticals Inc. has traded in a range of $45...